Added value of [18F]FDG PET/MRI over MDCT alone in the staging of recurrent gastric cancer.
Ieun YoonJae Seok BaeJeongin YooDong Ho LeeSe Hyung KimPublished in: European radiology (2021)
• [18F]FDG PET/MRI can improve diagnostic accuracy for preoperative M staging in patients with recurrent gastric cancers. • [18F]FDG PET/MRI can improve diagnostic accuracy for determining resectability in patients with recurrent gastric cancers. • [18F]FDG PET/MRI can provide critical clues for management options for recurrent gastric cancers.